We are a clinical-stage biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein.
$14.00 - $16.00
October 3, 2019
J.P. MORGAN SECURITIES LLC,MORGAN STANLEY & CO. LLC
To view the prospectus for Aprea Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253